Center Book Partners LP Day One Biopharmaceuticals, Inc. Transaction History
Center Book Partners LP
- $1.54 Billion
- Q4 2024
A detailed history of Center Book Partners LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Center Book Partners LP holds 100,735 shares of DAWN stock, worth $1.2 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
100,735Holding current value
$1.2 Million% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
175Shares Held
77.8MCall Options Held
139KPut Options Held
253K-
Atlas Venture Life Science Advisors, LLC6.43MShares$76.7 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$69.8 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$68.7 Million1.18% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$58.1 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$54.1 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $876M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...